NQO1 and cancer: Treatments involving dicumarol, an NQO1 inhibitor, potentiate the cytotoxic effects induced by chemotherapy drugs, such as cisplatin 9 or gemcitabine 10, on cancer cells; this result implies the involvement of NQO1 in cancer chemoresistance.